The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate of Abu Dhabi, announced that the desired number of participants aged 3 to 17 has been met for the Sinopharm immune bridge study. Under the supervision of the Ministry of Health and Prevention (MoHAP), the study followed the …

The post Abu Dhabi completes Sinopharm trials on 900 kids aged 3-17 appeared first on The Filipino Times.